Epigenetics and translational omics at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

16 organizations at FoG London 2027 present work in epigenetics & translational omics: 11 universities and research institutes, 4 suppliers and service providers and 1 NHS, government or non-profit body. Between them they bring 83 presentations to the program. Most represented: University of Oxford, UCL and Queen Mary University of London. As of Oct 29, 2026.

All 243 organizations at FoG London 2027 →

Format
Top represented
Showing 1–3 of 16 organizations
OrganizationFoG London 2027 Attendance
Universities & institutes
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research.
Talk
Wed Jan 27
11:30–12:00
Why Do We Sleep?
Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health.
Population & social genomics
Talk
Wed Jan 27
12:30–13:00
Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance
Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent.
Talk
Wed Jan 27
14:30–15:00
Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics
New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles.
Talk
Wed Jan 27
14:30–15:00
Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation
Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread.
Talk
Wed Jan 27
16:30–17:00
Accelerating the Development of Therapies for Rare Genetic Disease
How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases.
Talk
Wed Jan 27
16:30–17:00
The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines
How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics.
Talk
Wed Jan 27
16:30–17:00
The Body Clock in Your Blood: Circadian Signals in Omics Research
How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies.
Talk
Wed Jan 27
17:30–18:00
Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response
How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines.
Talk
Thu Jan 28
11:30–12:00
Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome
How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures.
Talk
Thu Jan 28
12:30–13:00
Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective
How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating.
Panel
Thu Jan 28
14:10–14:40
Is Modern Life Fighting Our Human Biology?
Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity.
with University of Cambridge, University of Leeds, Leeds Beckett University
Population & social genomics
Talk
Thu Jan 28
14:10–14:40
Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing
Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them.
Talk
Thu Jan 28
14:10–14:40
Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes
How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes.
Talk
Thu Jan 28
14:10–14:40
Why Endometriosis Is Not One Disease: Insights from Genetics
How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets.
Workshop
Thu Jan 28
14:10–15:40
Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation
Workshop Room · with EMBL, University of Surrey
Multi-omics & proteomics
Talk
Thu Jan 28
14:40–15:10
The MWS: 3 Decades of Research into the Effects of Menopausal Hormone Therapy on Women's Health
Women & Children's Health Stage
Talk
Thu Jan 28
15:10–15:40
Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example
How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain.
Panel
Thu Jan 28
15:10–15:40
Why Does Disease Spare Some of Us?
Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments.
with Imperial College London, University of Edinburgh
Population & social genomics
Talk
Thu Jan 28
16:10–16:40
Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development
How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it.
Workshop
Thu Jan 28
16:10–17:10
From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation
Workshop Room · with University of Edinburgh, NHS, North East and Yorkshire Genomic Laboratory Hub
Genomic medicine & rare disease
Talk
Thu Jan 28
16:40–17:10
Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease
How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working.
Talk
Thu Jan 28
16:40–17:10
Leveraging Big Data to Inform Cardiovascular Precision Medicine
How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment.
UCL
London, UK
Universities & institutes
Multidisciplinary London research university with faculties of medical, life, brain and population health sciences, including the Great Ormond Street Institute of Child Health.
Talk
Wed Jan 27
11:30–12:00
What Do We Need to Get More Advanced Therapies to Patients?
How regulatory changes in the US, UK and EU, plus practical rollout models, could bring more advanced therapies to patients.
Talk
Wed Jan 27
12:30–13:00
Quantitative Proteomics to Unravel Signaling in Rare Cells
How mapping protein phosphorylation in just hundreds of cells reveals dormant, drug-resistant glioblastoma cells and leftover disease in acute myeloid leukaemia.
Talk
Wed Jan 27
14:30–15:00
Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting
How large human brain RNA datasets link disease-associated genetic variants to genes and mechanisms in Lewy body disorders and related neurodegenerative diseases.
Talk
Wed Jan 27
15:30–16:00
Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion
How mapping cells in place across primary tumours and their metastases reveals the earliest steps of cancer spread and immune escape.
Talk
Wed Jan 27
15:30–16:00
Why Does the Food Environment Affect Us Differently?
What it means to call obesity genetic, how genes and food surroundings interact to shape weight, and what a twin study shows.
Population & social genomics
Talk
Wed Jan 27
16:30–17:00
Personalised Surveillance in Ovarian Cancer: Does It Work?
Whether tracking a blood tumour marker over time helps women at high genetic risk of ovarian cancer who are awaiting preventive surgery.
Talk
Wed Jan 27
16:30–17:00
Why Do We Age So DIfferently?
Why people with similar genes and lifestyles age at different rates, and what genetically identical organisms reveal about chance in ageing.
Population & social genomics
Talk
Thu Jan 28
10:30–11:00
Who Do We Think We Are? What the Last Decade of Genomics Has Revealed About Us
What ancient DNA has revealed about human migration and ancestry, and what genetics can and cannot say about race and identity.
Population & social genomics
Talk
Thu Jan 28
11:30–12:00
Ageing as a Modifiable Process: From Lifestyle to Therapeutic Intervention
How exercise, sleep, diet and social life shape ageing, and whether existing drugs could target ageing biology to delay disease.
Talk
Thu Jan 28
11:30–12:00
Beyond Screening: The Next Generation of Prenatal Genomics
Women & Children's Health Stage
Talk
Thu Jan 28
12:30–13:00
Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy
Why pregnant women were long excluded from clinical trials, how pregnancy research can now run safely, and what fetal gene therapy could offer.
Panel
Thu Jan 28
14:40–15:10
What Will Human Evolution Look Like Next?
Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next.
with Francis Crick Institute, University of Cambridge, Anglia Ruskin University
Population & social genomics
Talk
Thu Jan 28
16:10–16:40
25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential
How gene and cell therapies are moving from experiments toward potential cures for inherited blood diseases and cancer, and what blocks wider access.
Talk
Thu Jan 28
16:10–16:40
Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction
How to judge whether polygenic risk scores and blood protein markers really help with screening, risk grouping and predicting individual disease risk.
Talk
Thu Jan 28
16:40–17:10
From Research to Reality: Ensuring Women Benefit from Innovation
How to design women's health tests and technologies that work for all women, and who risks being left behind by them.
with University Hospital Southampton NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust
Universities & institutes
London research university with genomic medicine, computational biology, clinical pharmacology and population health research.
Talk
Wed Jan 27
11:30–12:00
AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics
How AI agents and large language models can speed up interpreting genetic variants for rare disease diagnosis within NHS genomic services.
Talk
Wed Jan 27
11:30–12:00
Pharmacogenomics in Healthcare
How health systems could adopt pharmacogenomics, testing genes to guide prescribing, and whether to test in advance or only when needed.
Talk
Wed Jan 27
11:30–12:00
Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing
How unusually low blood protein levels could help diagnose rare disease patients left undiagnosed after whole-genome sequencing, and flag new disease genes.
Talk
Wed Jan 27
11:30–13:00
Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes
Genome Dome · with University of Edinburgh, University of Surrey, The Alan Turing Institute +2 more
AI in drug discovery & diagnostics
Talk
Wed Jan 27
15:30–16:00
Telomere Biology Disorders: Insights into Early-Life Programming and Lifelong Disease Risk
How rare congenital disorders show why telomeres, the protective caps on chromosome ends, matter early in life and shape lifelong disease risk.
Talk
Thu Jan 28
14:10–14:40
From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care
How population genomic testing can find people at higher risk of women's cancers and guide targeted screening and prevention.
Talk
Thu Jan 28
15:10–15:40
A Human DNA Methylation Atlas for Epigenomic Interpretation
How an atlas of DNA methylation marks across healthy human cell types helps interpret epigenetic data and cell-free DNA in blood.
Talk
Thu Jan 28
16:40–17:10
Rethinking Monogenic DIsease in the Era of Population Genomics
How population-scale genome data and new ways to detect repeated DNA sequences are changing how single-gene diseases are understood.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in epigenetics & translational omics

Tell us what you sell and we’ll find the people at organizations working on epigenetics & translational omics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse FoG London 2027 by

Exhibit hall

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction